Literature DB >> 24254710

Validation of the J-chronic total occlusion score for chronic total occlusion percutaneous coronary intervention in an independent contemporary cohort.

Luis Nombela-Franco1, Marina Urena, Miguel Jerez-Valero, Can Manh Nguyen, Henrique Barbosa Ribeiro, Yoann Bataille, Josep Rodés-Cabau, Stéphane Rinfret.   

Abstract

BACKGROUND: Chronic total occlusion (CTO) recanalization is a complex and technically challenging procedure. The J-CTO score has been proposed to stratify case complexity and procedural success rates. However, the score has never been tested outside the setting of the original study. Moreover, its predictive value when using a hybrid antegrade or retrograde approach is unknown. We investigated the performance of the J-CTO score for predicting procedure complexity and success in an independent contemporary cohort. METHODS AND
RESULTS: A total of 209 consecutive patients who underwent CTO recanalization by a high-volume operator were included. Clinical and angiographic data were prospectively collected. The J-CTO score was applied for each patient, and discrimination and calibration were evaluated in the whole cohort, and according to the approach (antegrade 47% and retrograde 53%). Clinical and angiographic differences were noted between the original and studied cohort. The mean J-CTO score was 2.18±1.26, and successful guidewire crossing within 30 minutes and final angiographic success were 44.5% and 90.4%, respectively. The J-CTO score demonstrated good discrimination (c statistic, >0.70) and calibration (Hosmer-Lemeshow P>0.1) in the whole cohort and for antegrade and retrograde approaches. However, the final success rate was not associated with the J-CTO score.
CONCLUSIONS: In this independent cohort, the J-CTO score showed good discriminatory and calibration capacity for guidewire CTO crossing within 30 minutes but it does not for final success rate. The J-CTO score helps to predict complexity of CTO recanalization, and the simplicity of the score supports the widespread use as a clinical tool.

Entities:  

Keywords:  chronic disease; coronary occlusion; percutaneous coronary intervention

Mesh:

Year:  2013        PMID: 24254710     DOI: 10.1161/CIRCINTERVENTIONS.113.000447

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   6.546


  23 in total

Review 1.  A contemporary review of clinical significances of percutaneous coronary intervention for chronic total occlusions, with some Japanese insights.

Authors:  Yoshihiro Morino
Journal:  Cardiovasc Interv Ther       Date:  2021-03-03

Review 2.  Approach to CTO Intervention: Overview of Techniques.

Authors:  Aris Karatasakis; Barbara Anna Danek; Dimitri Karmpaliotis; Khaldoon Alaswad; Minh Vo; Mauro Carlino; Mitul P Patel; Stéphane Rinfret; Emmanouil S Brilakis
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-01

3.  Scoring systems for chronic total occlusion percutaneous coronary intervention: if you fail to prepare you are preparing to fail.

Authors:  Aris Karatasakis; Barbara Anna Danek; Emmanouil S Brilakis
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

Review 4.  Update on the Management of Chronic Total Occlusions in Coronary Artery Disease.

Authors:  Kathleen Kearney; Ravi S Hira; Robert F Riley; Arun Kalyanasundaram; William L Lombardi
Journal:  Curr Atheroscler Rep       Date:  2017-04       Impact factor: 5.113

5.  Application and outcomes of a hybrid approach to chronic total occlusion percutaneous coronary intervention in a contemporary multicenter US registry.

Authors:  Georgios Christopoulos; Dimitri Karmpaliotis; Khaldoon Alaswad; Robert W Yeh; Farouc A Jaffer; R Michael Wyman; William L Lombardi; Rohan V Menon; J Aaron Grantham; David E Kandzari; Nicholas Lembo; Jeffrey W Moses; Ajay J Kirtane; Manish Parikh; Philip Green; Matthew Finn; Santiago Garcia; Anthony Doing; Mitul Patel; John Bahadorani; Muhammad Nauman J Tarar; Georgios E Christakopoulos; Craig A Thompson; Subhash Banerjee; Emmanouil S Brilakis
Journal:  Int J Cardiol       Date:  2015-06-27       Impact factor: 4.164

Review 6.  Advances in the management of coronary chronic total occlusions.

Authors:  Emmanouil S Brilakis; Dimitri Karmpaliotis; Minh N Vo; Santiago Garcia; Lampros Michalis; Khaldoon Alaswad; Parag Doshi; William L Lombardi; Subhash Banerjee
Journal:  J Cardiovasc Transl Res       Date:  2014-03-15       Impact factor: 4.132

7.  Predictive scores in chronic total occlusions percutaneous recanalization: only fashionable or really useful?

Authors:  Marouane Boukhris; Kambis Mashayekhi; Zied Ibn Elhadj; Alfredo R Galassi
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

8.  Effect of Previous Failure on Subsequent Procedural Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention (from a Contemporary Multicenter Registry).

Authors:  Judit Karacsonyi; Aris Karatasakis; Dimitri Karmpaliotis; Khaldoon Alaswad; Robert W Yeh; Farouc A Jaffer; Michael R Wyman; William L Lombardi; J Aaron Grantham; David E Kandzari; Nicholas Lembo; Jeffrey W Moses; Ajay J Kirtane; Manish A Parikh; Philip Green; Matthew Finn; Santiago Garcia; Anthony Doing; Mitul Patel; John Bahadorani; Jose Roberto Martinez Parachini; Erica Resendes; Bavana V Rangan; Imre Ungi; Craig A Thompson; Subhash Banerjee; Emmanouil S Brilakis
Journal:  Am J Cardiol       Date:  2016-01-28       Impact factor: 2.778

9.  Chronic total occlusion percutaneous coronary intervention in 2014 beyond the J-CTO score (Japanese Multicenter CTO Registry): chance favors the prepared mind.

Authors:  Dimitrios Karmpaliotis; Philip Green
Journal:  JACC Cardiovasc Interv       Date:  2015-02       Impact factor: 11.195

10.  A Novel Risk Score in Predicting Failure or Success for Antegrade Approach to Percutaneous Coronary Intervention of Chronic Total Occlusion: Antegrade CTO Score.

Authors:  Mohammad Hasan Namazi; Ali Reza Serati; Hosein Vakili; Morteza Safi; Saeed Ali Pour Parsa; Habibollah Saadat; Maryam Taherkhani; Sepideh Emami; Shamseddin Pedari; Masoomeh Vatanparast; Mohammad Reza Movahed
Journal:  Int J Angiol       Date:  2016-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.